Who owns the Z THE ZELLA TRIAL trademark?

The Z THE ZELLA TRIAL trademark is owned by Sumitomo Dainippon Pharma Co., Ltd..

What is the serial number for Z THE ZELLA TRIAL?

The USPTO serial number for Z THE ZELLA TRIAL is 79255703.

What is the registration number for Z THE ZELLA TRIAL?

Z THE ZELLA TRIAL is registered under USPTO registration number 5999157.

ZTH

USPTO Trademark Record

REGISTERED

Z THE ZELLA TRIAL

Q: What class is the Z THE ZELLA TRIAL trademark registered in?

The Z THE ZELLA TRIAL trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

SN 79255703·Reg 5999157·Filed Dec 05, 2018

Owner Sumitomo Dainippon Pharma Co., Ltd.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

Z THE ZELLA TRIAL (Serial No. 79255703), Registration No. 5999157, is a registered US trademark filed on Dec 05, 2018 by Sumitomo Dainippon Pharma Co., Ltd.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

Section 8/9 declaration window: March 04, 2030

Mark Intelligence

Z THE ZELLA TRIAL (Reg. #5999157) is a registered US trademark that has been protecting its owner, Sumitomo Dainippon Pharma Co., Ltd., since 2018. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 05, 2018

SERIAL

79255703

REG#

5999157

REGISTERED

Mar 03, 2020

Owner

Applicant

Sumitomo Dainippon Pharma Co., Ltd.

Entity

Corporation

Address

6-8, Doshomachi 2-chome,, Chuo-ku, Osaka-shi Osaka 541-0045

Country

Attorney

NameHoward N. Aronson

Law firm

Howard N. Aronson Lackenbach Siegel LLP

Docket

21538

Address

1 Chase Rd., Lackenbach Siegel Bldg., Scarsdale, NY 10583-4156, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 05, 2018

Serial Number79255703

Registration No.5999157

Registration DateMar 03, 2020

Status DateMar 03, 2020

Published for OppositionDec 17, 2019

Next RenewalMarch 04, 2030

Mark TypeDesign with words

Attorney Docket21538

Status DescriptionLive and registered

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

30 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Mar 03, 2025

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Jul 31, 2020

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jul 14, 2020

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jul 14, 2020

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 03, 2020

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Mar 03, 2020

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Dec 17, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 17, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 27, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Nov 12, 2019

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Nov 12, 2019

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 12, 2019

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Nov 12, 2019

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 12, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 07, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 07, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Nov 04, 2019

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 29, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 28, 2019

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 28, 2019

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

REFUSAL PROCESSED BY IB

May 25, 2019

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

May 04, 2019

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 04, 2019

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

APPLICATION FILING RECEIPT MAILED

Apr 16, 2019

APPLICATION FILING RECEIPT MAILED

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Apr 12, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 11, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Apr 11, 2019

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Apr 11, 2019

NON-FINAL ACTION WRITTEN

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Apr 10, 2019

LIMITATION FROM ORIGINAL APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 04, 2019

SN ASSIGNED FOR SECT 66A APPL FROM IB

Z THE ZELLA TRIAL

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Sumitomo Dainippon Pharma Co., Ltd.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Howard N. Aronson

Resources

Company